Table 1:

Summary of FA and MD (×10⁻³ mm²s⁻¹) values quantified in patients with PKAN, their siblings, and age-matched healthy controls in deep gray matter nuclei and ALIC

Subject	CN		Putamen		GP		SN		ALIC
Subject	FA	MD	FA	MD	FA	MD	FA	MD	FA	MD
Control (n = 5)	0.10 ± 0.01	0.76 ± 0.02	0.08 ± 0.01	0.70 ± 0.01	0.10 ± 0.01	0.70 ± 0.01	0.19 ± 0.01	0.69 ± 0.11	0.35 ± 0.01	0.71 ± 0.02
Sibling (n = 5)	0.10 ± 0.01	0.77 ± 0.02	0.08 ± 0.01	0.71 ± 0.01	0.11 ± 0.02	0.72 ± 0.02	0.22 ± 0.02	0.69 ± 0.12	0.35 ± 0.01	0.72 ± 0.01
Patient (n = 7)	0.10 ± 0.01	0.77 ± 0.03	0.08 ± 0.01	0.70 ± 0.02	0.18 ± 0.03	0.75 ± 0.06	0.32 ± 0.02	0.67 ± 0.10	0.36 ± 0.01	0.71 ± 0.03
P value^a	.17	.23	.31	.10	<.001	<.001	<.001	.71	.83	.16

a ANOVA.